Prader Willi Syndrome Treatment News and Information

What is Prader Willi Syndrome?

According to the Prader-Willi Syndrome Association, PWS is a complex genetic disorder affecting appetite, growth, metabolism, cognitive function and behavior. In infancy, this rare condition is characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth, and delayed development. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity which sometimes leads to Type 2 Diabetes. It is believed that PWS is caused by deletion of a part of chromosome 15 passed down by the father.

See below for updated news and information regarding Prader Willi Syndrome including new medical research, treatment options and advancements. 

Latest Prader Willi Syndrome Treatment News and Research

Prader Willi Syndrome Research News: Experimental therapy for Prader-Willi syndrome shows promise in mice

(SOURCE: NIH/EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT) - NIH-funded study describes strategy that activates silenced genes. Drugs capable of activating silenced genes improve survival and growth outcomes in a mouse model of Prader-Willi syndrome (PWS), a rare and incurable childhood disease, according to a study funded by the National Institutes of Health (NIH). PWS occurs in 1 ...
Read More